Targeted radiotherapy to the skeleton using 166HO-DOTMP with autologous stem cell transplantation for patients with bone-only metastatic breast cancer

被引：2
|
作者：
Champlin, RE [1 ]
Booser, D [1 ]
Rondon, G [1 ]
Williams, PA [1 ]
Wendt, R [1 ]
Hortobagyi, G [1 ]
Ueno, N [1 ]
Podoloff, D [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.249
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
249
引用
收藏
页码：84 / 85
页数：2
相关论文
共 50 条
  • [31] Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
    Schrama, JG
    Rodenhuis, S
    de Gast, GC
    BONE MARROW TRANSPLANTATION, 2003, 31 (02) : 141 - 142
  • [32] Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer
    Schneeweiss, A
    Hensel, M
    Goerner, R
    Khbeis, T
    Hohaus, S
    Egerer, G
    Solomayer, E
    Haas, R
    Grischke, EM
    Bastert, G
    Ho, AD
    STEM CELLS, 2001, 19 (02) : 151 - 160
  • [33] Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
    LF Porrata
    JN Ingle
    MR Litzow
    S Geyer
    SN Markovic
    Bone Marrow Transplantation, 2001, 28 : 865 - 871
  • [34] Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
    Porrata, LF
    Ingle, JN
    Litzow, MR
    Geyer, S
    Markovic, SN
    BONE MARROW TRANSPLANTATION, 2001, 28 (09) : 865 - 871
  • [35] Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
    J G Schrama
    S Rodenhuis
    G C de Gast
    Bone Marrow Transplantation, 2003, 31 : 141 - 142
  • [36] Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer
    Reece, DE
    Foon, KA
    Bhattacharya-Chatterjee, M
    Hale, GA
    Howard, DS
    Munn, RK
    Nath, R
    Plummer, BA
    Teitelbaum, A
    Phillips, GL
    BONE MARROW TRANSPLANTATION, 2000, 26 (07) : 729 - 735
  • [37] Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer
    Hamaoka, T.
    Costelloe, C. M.
    Madewell, J. E.
    Liu, P.
    Berry, D. A.
    Islam, R.
    Theriault, R. L.
    Hortobagyi, G. N.
    Ueno, N. T.
    BRITISH JOURNAL OF CANCER, 2010, 102 (04) : 651 - 657
  • [38] Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer
    Barton, TD
    Collis, T
    Stadtmauer, E
    Schuster, MG
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) : 391 - 395
  • [39] Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer
    T Hamaoka
    C M Costelloe
    J E Madewell
    P Liu
    D A Berry
    R Islam
    R L Theriault
    G N Hortobagyi
    N T Ueno
    British Journal of Cancer, 2010, 102 : 651 - 657
  • [40] Circulating tumor cells (CTCs) and Autologous hematopoietic stem cell transplantation in triple negative metastatic breast cancer
    Reuben, J. M.
    Mego, M.
    Gao, H.
    Ueno, N. T.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S115 - S116
12345